Intervention Packages to Reduce the Impact of HIV and HCV Infections Among People Who Inject Drugs in Eastern Europe and Central Asia: A Modeling and Cost-effectiveness Study
Author(s) -
Guillaume Mabileau,
Otilia Scutelniciuc,
Maia Tsereteli,
Ivan Konorazov,
Alla Yelizaryeva,
Svetlana Popovici,
Saifuddin Karimov,
Elena Losina,
Manoela Manova,
Vinay Saldanha,
JeanElie Malkin,
Yazdan Yazdanpanah
Publication year - 2018
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofy040
Subject(s) - medicine , human immunodeficiency virus (hiv) , intervention (counseling) , virology , environmental health , nursing
Increasing NSP+OST coverage, in addition to ART and HIV diagnosis, had a high impact on both epidemics and was very cost-effective and even cost-saving. When HCV diagnosis was improved, increased DAA averted a high number of new infections if associated with NSP+OST.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom